Navigation Links
Jazz Pharmaceuticals Appoints Head of Research and Development
Date:9/27/2011

PALO ALTO, Calif., Sept. 27, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company has appointed Jeffrey Tobias, MD, as Senior Vice President of Research & Development and Chief Medical Officer, effective October 17.

"Jeff has a unique combination of drug development skills and broad medical knowledge, combined with a passion for the commercial side of the business," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  "His breadth of experience, business acumen, strong intellect and focus on patients will serve us well as we build a targeted pipeline of important new medical treatments that will complement our growing commercial products."

Dr. Tobias has twenty years of experience in the biopharmaceutical industry across all phases of drug development, including regulatory filings in the U.S. and Europe.  He has broad experience with a variety of therapeutic products spanning numerous clinical areas, including pain and neurological disorders.  Most recently, he served as Executive Vice President of Research & Development at NeurogesX, where he has also been Chief Medical Officer since 2005.  He was previously Managing Director of an independent biopharmaceutical consulting firm from 1996 to 2006, where he supported clients in all aspects of clinical development, technology assessment and strategic planning.  Prior to that, he served in various roles in drug discovery and clinical development at ALZA, Chiron and XOMA. 

In addition to his expertise in the creation, evaluation, and development of novel products utilizing proprietary drug-delivery technologies, Dr. Tobias has ten years of experience in clinical and academic medicine in the areas of internal medicine, pulmonary and critical care medicine.  He received board-certification in both Interna
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , October 24, 2014 ... ) has announced the addition of the  ... 2014"  report to their offering.  ... and Chinese Acne Medication Industry Report 2014 ... the current state of the global acne ...
(Date:10/25/2014)... Oct. 24, 2014  As the building blocks ... company access to diverse skill sets and expertise, ... clock business hours for efficiency. However, effectively managing ... According to recent research, more than ... seeing a project not move forward due to ...
(Date:10/22/2014)... 22, 2014  Rescheduling of hydrocodone combination products ... pain market, according to a new primary market ... providing market research and consultation exclusively in the ... http://photos.prnewswire.com/prnh/20141021/153440 In August, ... combination products from Schedule III to Schedule II ...
Breaking Medicine Technology:Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3
... 2011 The GlaxoSmithKline 15th Annual IMPACT Awards target ... underserved. Up to ten organizations in the Pennsylvania Counties ... Philadelphia and in the City of Camden, New Jersey, ... are bestowed upon winning organizations for success and achievements ...
... American Scientific Resources, Inc. (Pink Sheets: ... non-contact thermometer. Updating the packaging to a brighter cleaner ... thermometer. "We made the changes to distance ... foreign model previously sold by American Scientific Resources; to ...
Cached Medicine Technology:GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits 2American Scientific Resources Rebrands Non-Contact Thermometer for Mass Market Consumer Appeal 2
(Date:10/25/2014)... WI (PRWEB) October 25, 2014 ... tax-advantaged medical and other benefits account management services, ... to help employers save on taxes, reduce administrative ... Suites provide tax savings and the efficient handling ... pick the Suite that best meets their goals ...
(Date:10/25/2014)... New York (PRWEB) October 25, 2014 ... mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed against ... underway in U.S. District Court, Southern District of ... Summary Judgment on Punitive Damages in a group ... In a ruling issued on October 21st, U.S. ...
(Date:10/25/2014)... Oct. 24, 2014 (HealthDay News) -- Not getting the ... ulcerative colitis, a new study suggests. Those who ... eight hours per night may be more prone to ... intestines, researchers report. The study authors concluded that duration ... considered among patients with inflammatory bowel diseases. "Both ...
(Date:10/25/2014)... News) -- October,s shorter, darker days can trigger a ... to an expert. People affected by seasonal ... lack motivation and even have trouble getting out of ... said Dr. Angelos Halaris, a professor in the department ... Stitch School of Medicine. "Seasonal affective disorder should ...
(Date:10/22/2014)... MI (PRWEB) October 22, 2014 ... Schools of Allied Health Professions (ASAHP) Conference on October ... and CEO will participate in a panel discussion on ... Practice. , Isabel Healthcare provides a diagnostic decision support ... improving the diagnosis skills of students and clinical learners. ...
Breaking Medicine News(10 mins):Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2
... manufactured by Merck & Co would result in an increased ... taking the drug. // Statistics show that about 60 patients ... six to 13 days after they first started taking Vioxx. ... Journal. It was contrary to what Merck had previously told ...
... of the Food and Drug Administration has been subjected ... // ,Attorney Barbara Van Gelder has mentioned ... of Lester Crawford. She is believed to have ... Thursday, that she would instruct him to invoke his ...
... and polio immunization campaign commenced with a bit of ... with their children to avail immunization, // and this ... Infact, the stock of vaccines started getting depleted by ... of the vaccination drive. ,Assistant Minister for Medical ...
... hypothermia to help patients with severe heart disease or ... Dalton Dietrich and his colleagues noticed// that the rats ... stroke, but had different responses. ,"We ... temperatures in the rats' brains they found that rates ...
... University Medical School in Melbourne, Australia, it was found ... than a very low-calorie diet.// The surgical procedure consists ... stomach to create a feeling of fullness in patients ... those who have serious medical conditions, such as type ...
... A study conducted by a Brown Medical School professor ... say that postpartum depression is linked to fussy babies.//, ... clinical professor of paediatrics at Brown Medical School and ... Other members include Rhode Island Department of Health's Division ...
Cached Medicine News:
... Used to establish and maintain ... ureteral segment promotes patency and allows ... subsides. Supplied sterile in peel-open packages. ... evaluation is advised; stent must not ...
... drainage following open renal or bladder ... provide enhanced drainage and promote catheter ... for enhanced patient comfort and provides ... Supplied sterile in peel-open packages. Intended ...
... Used for percutaneous ... catheter in the renal ... Supplied sterile in peel-open ... use. CAUTION: Periodic evaluation ...
... contains primers and a FAM-labeled probe targeting the ... Parvo B19 ASR contains primers and a Texas ... ASR requires an instrument that can detect FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
Medicine Products: